Cancer immunotherapy - Medicow
About us  |  Why use us?  |  Press  |  Contact us

 

Topic: Cancer immunotherapy


  
 Immunotherapy Cancer Treatment
Immunotherapy seems to offer great promise as a new dimension in cancer treatment, but it is still very much in its infancy.
One immediate goal of research in cancer immunology is the development of methods to harness and enhance the body's natural tendency to defend itself against malignant tumors.
Cancer vaccines typically consist of a source of cancer-associated material (antigen), along with other components, to further stimulate the immune response against the antigen.
http://www.cancersupportivecare.com/immunotherapy.html

  
 Immunotherapy for Cancer
Many people are using natural and alternative treatments for cancer.
Interferon was the first type of lymphokine therapy to be investigated.
This type therapy shows some promise but is still regarded as experimental.
http://www.cancer-info.com/immuno.htm

  
 Immunotherapy for Cancer - Introduction
Weber explores the role of cytokines in cancer therapy, one of the cornerstones of immunotherapy.
More attainable, however, is the goal of developing therapies that might change the potentially fatal course of cancer to one of long-term management.
Our hope is always that these therapies might yield cures – the universal object of researchers, healthcare providers, and patients.
http://www.meds.com/immunotherapy/intro.html

  
 Cancer Treatment and Autologous Immunotherapy
With the ever-increasing incidence of cancer, our general medical health care is faced with the threat that national economies will soon not be able to cope with the expense of acceptable treatment modalities for cancer.
It seems to be essential for renal cancer patients suffering from bone metastases to ingest, especially, orthovanadate and neurogenic lipid components.
The experimental studies have been designed in a way that if they lead to a positive effect on the cancer, evidenced as increased survival time and regression of tumour masses, the therapy modality should be applicable to human patients without major changes.
http://www.acnem.org/journal/15-1_april_1996/cancer_treatment_and_autologous_immunotherapy.htm

  
 Approaches to Treating Cancer - Immunotherapy
Immunotherapy is a comparatively new treatment that seeks to harness the body's own immune system to fight cancer and other diseases.
Today immunotherapy is used against cancer and clinical applications continue to evolve as a result of the new research.
They usually are applied in combination with more common cancer treatments, such as surgery, chemotherapy and autologous bone marrow transplants.
http://www.cancerrx.com/Immunotherapy.htm

  
 Immunotherapy in the Treatment of an Adenoma Prostate and Prostate Cancers
In certain cases, for example where the cancer is more aggressive and surgery or radiation is not possible, it is used as a major therapy.
Hormonal therapy (androgen ablation therapy) though usually reserved for advanced prostate cancer, can be combined with the primary treatment plan (post-prostatectomy or with radiation therapy) as a supplementary therapy, especially where there is high risk of recurrences.
So, the prostate problems particularly prostate cancer remains a difficult clinical problem regardless of intensive scientific research works and billions of dollars spent every year in the research and development of novel therapy strategies for their effective control and treatment.
http://www.anticancer.net/resan/prostate.html

  
 Society : Disease Information - Immunotherapy
One reason for reexamining immune therapy for cancer arose from an observation during the study of marrow transplantation.
Researchers are studying immunotherapy with three general approaches.
Treating Cancer with Vaccine Therapy Web site, National Cancer Institute, 2000.
http://www.leukemia-lymphoma.org/all_page?item_id=18551

  
 Bladder Cancer WebCafe - Immunotherapy
Immunotherapy - also referred to as biological therapy, biotherapy or biological response modifier therapy - is a relatively new treatment for cancer.
These therapies use the body's immune system, either directly or indirectly, to fight cancer.
Researchers continue to discover new BRMs, learn more about how they function, and develop ways to use them in cancer therapy.
http://blcwebcafe.org/immunotherapy.asp

  
 Prostate cancer immunotherapy vaccine hits clinical trials
200 new therapies are being developed for prostate cancer
Scientists at the Austrlia's, Queensland Institute of Medical Research (QIMR) are currently trialing an experimental "immunotherapy" treatment for men with advanced prostate cancer.
Radiation therapy after surgery for men with prostate cancer lessens the chance of the cancer returning
http://www.news-medical.net/?id=2327

  
 Future Perspectives in Cancer Immunotherapy Over 675 industry related cancer - Press Release
Immunotherapy has for some time been heralded as a breakthrough approach for cancer treatment.
Experts have analyzed more than 675 industry related cancer immunotherapy R&D projects including more than 425 clinical trials of which 60 are in phase III.
The concept of utilizing the immune system for the treatment of cancer has been tried for some time without any direct breakthrough success.
http://cancer.press-world.com/v/63343.html

  
 SHN: Prostate Cancer Immunotherapy
Murphy says he and his colleagues turned their efforts toward bolstering patients' immune systems for a simple reason: if prostate cancer returns after initial treatment, there is very little doctors can now offer their patients.
Since standard therapy has little to offer men with metastatic prostate cancer, any new option is welcome, but Dr. Murphy stresses that these trials are just the initial steps toward effective immunotherapy of prostate cancer.
Murphy says the fact that even a few patients have responded in the first two rounds of experiments is a significant advance.
http://www.nasw.org/users/holtza/SHNPCaImmuno.html

  
 Cancer Immunotherapy
Most cancer patients are treated with some combination of surgery, radiation, and chemotherapy.
Many such conjugates have been tried but only two have found their way into anticancer therapy.
They may be fused with a stimulatory molecule such as granulocyte-monocyte colony-stimulating factor ( GM-CSF)
http://users.rcn.com/jkimball.ma.ultranet/BiologyPages/C/CancerImmunotherapy.html

  
 [No title]
Many cancer doctors now regard immunotherapy as the "fourth modality," or fourth way, to treat cancer.
Many advances against cancer in the future will probably come from this field.
Find out how this treatment uses your body's own defense system to fight cancer.
http://www.cancer.org/docroot/ETO/eto_1_3_Immunotherapy.asp

  
 James P. Wilmot Cancer Center - Cancer Cancer - Patient Care - Treatment - Immunotherapy
Immunotherapy stimulates the body’s own defense system to recognize and attack cancer.
Although immunotherapy shows great promise for the future, it has a small role in treating the most common types of cancer today.
Biological Therapies: Using the Immune System To Treat Cancer
http://www.stronghealth.com/services/cancer/treatment/immunotherapy.cfm

  
 MEDICAL BIOLOGY: ON CANCER IMMUNOTHERAPY
Although the term has been most often associated with therapies for established malignancies (1-5), immunotherapy is of increasing interest as an approach to arrest cancer at a much earlier stage.
Not enough is known about how the human immune system works or how it responds, not just to cancer but to many other diseases, such as autoimmune disorders and allergy.
4) Immunotherapy lends itself to such basic research in patients, since the immune system can often be assessed and even manipulated with relatively few risks.
http://scienceweek.com/2004/sa040924-4.htm

  
 Cancer Immunity - Links
Topics include "Cancer Therapy: Immunotherapy", "Cancer Therapy: Vaccines" and "Cytokines in cancer"
The goal of the consortium is to accelerate the process of bringing cancer vaccines from the development stage to the clinic
How the immune system works, cancer immunotherapy approaches, clinical trials and immunotherapy for specific cancers (includes references)
http://www.cancerimmunity.org/statics/links.htm

  
 Australian collaboration to produce cancer immunotherapy vaccines
QIMR has an international reputation in cancer research, with recent success in dendritic cell therapy in clinical trials for cancer immunotherapy.
The research, pre-clinical and clinical program at QIMR will be directed by Dr Chris Schmidt from the Cancer Immunotherapy laboratory and by Associate Professor Alejandro Lopez from the Dendritic Cell and Cancer therapy laboratory.
into Phase 1 clinical trials to be conducted by QIMR in association with its cancer immunotherapy vaccines.
http://www.news-medical.net/?id=3473

  
 The Cancer Immunology and Immunotherapy Page - CancerIndex
Society for Biological Therapy The Society was founded in 1984 to bring together researchers investigating biologicals and biological response modifiers in the diagnosis and treatment of cancer and other conditions.
Cancer Research Institute (USA) Supports national research into new cancer treatments, especially immunotherapy
An independent, non-profit research + development of novel biological therapies for cancer
http://www.cancerindex.org/clinks4i.htm

  
 IMMUNOTHERAPY OF CANCERS, Reviewed Materials, Guidelines & Links...
Cancer vaccines are an emerging type of biological therapy that is still experimental.
This vaccine is most beneficial in treating carcinomas and melanomas, and it is also indicated for some sarcomas (cancers of muscle, bone, and connective tissue) and in leukemia.
In Pennsylvania (Philadelphia) is conducted Phase I clinical trial to study the effectiveness of Tricom vaccine therapy with or without sargramostim in treating patients who have advanced or metastatic cancer (NLM Identifier http://clinicaltrials.gov/show/NCT00028496).
http://www.anticancer.net/reviews

  
 Scientific American: Article: Immunotherapy for Cancer: 9/96
A more achievable aim, though, may be developing therapies that can change the nature of cancer from a progressive and lethal disease to one that can be controlled throughout a long life.
Treating the cancer cells left behind after surgery-or those beginning to spread to some other site-makes much sense, and all forms of immunotherapy will undoubtedly focus on this goal in the future.
Today we would describe Coley's approach to cancer therapy as nonspecific: it strengthened the overall activity of the immune system instead of selectively arousing those elements most able to combat cancers.
http://www.sciencedigest.org/IMTPCAN.HTM

  
 Dr. Arnold Smith's Cancernet at the North Central Mississippi Regional Medical Center
Combined with radiation therapy to debulk cancer, molecular targeted therapies to arrest host defenses, genomic assays, and chemotherapy when necessary, immunotherapy helps patients live a higher-quality, longer life.
Twenty-one year lung cancer survivor John Reese talks about attitude, negativity, why a positive attitude helps patients, chemotherapy, and the healing power of the immune system.
Arnold Smith and his dedicated team at the North Central Mississippi Regional Cancer Center employ immunotherapy, an innovative treatment that works to restore the immune system that age and cancer break down, helping the body fight back.
http://www.cancernet.com

  
 Duke University Medical Center- Genitourinary Cancer Immunotherapy Program
Our long-term goal is to develop a multi-pronged approach that will allow us to overcome principal hurdles preventing progress in the immunologic treatment of cancer by inducing potent anti-tumor responses, preventing immune evasion, eliminating tumor-mediated immunosuppression, and enhancing the persistence of the vaccine-mediated antitumor response.
Welcome from the Director, Johannes Vieweg, M.D., F.A.C.S. The Genitourinary Cancer Immunotherapy Program, established within the Division of Urology, Department of Surgery, is focused on the preclinical development and initial clinical testing of innovative immunotherapies and other emerging medical technologies.
Duke University Medical Center- Genitourinary Cancer Immunotherapy Program
http://www.dukecancervaccines.org

  
 The Global Structure of Cancer Immunotherapy R&D (BioSeeker Group AB)
This up-to-date characterization and structuring of the cancer immunotherapy field provides a solid platform for your own independent studies in the field.
Graphs are analyzing relationships between different parameters important to provide a complete understanding of this fast moving field of cancer therapeutics.
In this 450+ page report our focus has been to completely review the cancer research activities in these key therapy groups.
http://www.canbiotech.com/reportsStore_2428.asp?itemId=507&countryCode=CA

  
 Table of contents for Immunotherapy of cancer
Interleukin-2 as Cancer Therapy Joseph I. Clark and Kim A. Margolin 21.
Different Approaches to Dendritic Cell-Based Cancer Immunotherapy Noweeda Mirza and Dmitry Gabrilovich 9.
Statistical Analysis of Immune Response Assays in Cancer Immunotherapy Trials Susan Groshen 6.
http://www.loc.gov/catdir/toc/ecip0514/2005017065.html

  
 Cancer Immunotherapy - Market Research Report
Monoclonal antibody therapy for cancer is now a reality, furthering the opportunities for companies interested in developing monoclonal antibody therapeutics, diagnostics, and vaccines.
Approximately 135 cancer vaccines are in either preclinical or clinical development by over 90 companies and institutions worldwide.
• New Cancer Therapeutics: An analysis of current and emerging markets
http://www.mindbranch.com/products/R206-005.html

  
 Immunotherapy / Immune-based therapy (IBT)
Even if immunotherapy does reach its theoretical potential, it is unlikely to rival traditional chemotherapy, radiation, or surgery.
In the case of low titer IgG response that predominate in immunosuppressed conditions such as cancer, early studies using autologous selection of phage-displayed primary tumor cDNA repertoires were unsuccessful, although selections with both mAbs and polyclonal rabbit sera did recover specific ligands.
This is an exceptionally high response rate in the context of clinical studies with other cancer vaccines.
http://focosi.altervista.org/immunotherapy.html

  
 Kidney Cancer - Immunotherapy
It is important to realize that medications to relieve pain do not interfere with other treatments, and that there are new approaches to pain medication that do not prevent a patient from being alert and active.
This approach is being tested in very early stages and it is not yet known if it will be more effective than standard immunotherapy with cytokines.
Radiation therapy can be used to reduce symptoms of some metastases.
http://www.cornellurology.com/cornell/kidney/treatments/immunotherapy.shtml

  
 Nov/Dec SFM:Immunotherapy for Cancer
These findings have set the stage for oncologists to stimulate the immune system in an attempt to reject a growing cancer in humans.
Can such an approach be applied successfully to the fight against cancer?
At best, the response rate has been about 10 percent to 20 percent.(1)
http://www.sfms.org/sfm/sfm1104a.htm

  
 Institute International Cancer Immunotherapy Symposia Series
These annual meetings, developed by CRI and organized in conjunction with the Academy of Cancer Immunology, focus attention on progress in the two central approaches of cancer immunology -- cancer vaccines and antibody-based therapies.
The international symposia series is a powerful means of shaping the future course of cancer research.
Ellen Puré, Ph.D., The Wistar Institute and the Ludwig Institute for Cancer Research
http://www.cancerresearch.org/crisymposium.html

  
 Cancer treatments chemotherapy radiotherapy immunotherapy hormonetherapy
Drugs given to support cancer therapies or symtoms.
Ongoing Clinical research trials in UK and internationally
http://www.cancernet.co.uk

  
 Cancer: Immunotherapy
This makes immunotherapy one of the most promising areas in cancer research today.
It appears that good results may be achieved by combining this therapy with other therapies.
Preventive cancer vaccines are being developed against cancers known to be associated with viruses.
http://www.bmhcc.org/health/library/canc3465.asp

  
 Immunotherapy for colon cancer
Whether or not it would benefit stage III patients in addition to chemotherapy is an issue that they intend to assess in future trials.
I appreciate this correction and the clarification of randomization and consent.
Active specific immunotherapy with vaccines prepared from the patient's own tumor has shown some success in patients with melanoma and renal cell cancer.
http://www.journalclub.org/vol2/a69.html

  
 Immunotherapy for Cancer
National Cancer Institute, Bethesda, MD Mary L. Disis, MD
Albert Einstein College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Norris Cancer Center, Los Angeles, CA Accreditation Statements
http://www.meds.com/immunotherapy

  
 Cancer immunotherapy
Therapeutic approaches to cancer involving the immune system
found that regular aspirin use reduced incidence of colon cancer
first MAB licensed for cancer treatment in USA
http://www.bitsplace.com/bitsplace/Cancerimmunocomp.html

  
 Cancer Immunotherapy - Supplying The Wake Up Call
In general much less is known about these tumour antigens, which tend to be slightly longer than those presented by MHC class I. Dr Pawelec's approach to treating cancer is called adoptive immunotherapy.
Outside the body, T cells are stimulated using the tumour antigens and are then reinfused into the patient where they attack the cancerous cells.
He says, "Treatment of patients with T cells specifically sensitized to their tumour cell antigens together with this antibody might therefore be especially effective at controlling the cancer."
http://www.eurekalert.org/pub_releases/1997-11/BSFI-CIST-301197.php

  
 Immunotherapy of Cancer
Attendance at this conference will give you the opportunity to hear different approaches to immunotherapy and the latest data on performance in human clinical trials.
- Professor Peter Stern, Head of Cancer Research UK Immunology Group, PATERSON RESEARCH INSTITUE FOR CANCER RESEARCH
Debate with key players on translational research and the EU Clinical Trials Directive, ensuring that scientists and doctors are striving towards the same endpoint
http://www.allconferences.com/conferences/20040402044216

  
 Best Book Buys - Cancer - Immunotherapy Books
Potential Role of t Cells in Cancer Therapy
Books > Browse > Subject Category > Health & Fitness > Diseases / Cancer > Cancer - Immunotherapy
Subject Category > Health & Fitness > Diseases / Cancer > Cancer - Immunotherapy
http://www.bestwebbuys.com/Diseases-Cancer-N_10012489-books.html

  
 Age-dependent differences in the efficacy of cancer immunotherapy in C57BL and AKR mouse strains.
Consequently, the aim of the present study was to assess whether cancer immunotherapy has an age-dependent effect.
Age-dependent differences in the efficacy of cancer immunotherapy in C57BL and AKR mouse strains.
The stronger therapeutic effect of this immunomodulator in old mice might thus be due to an increased macrophage-mediated anti-tumoral effect.
http://www.arclab.org/medlineupdates/abstract_15236763.html

  
 Cancer Immunotherapy - CIMT
A cancer disease of the blood-forming system affecting the bone marrow and lymph nodes.
There are two different types of leukemia: the acute, occurring fast and violent, and the chronical form developing slowly.
The second group includes vaccination, application of antibodies and the transfer of T-cells.
http://www.c-imt.org/enzyclopedia.html

  
 IBT - Cancer Immunotherapy
Dendritic cells are the most promising target for a cell-based immunotherapy of cancer and several methods have been devised for successful loading of dendritic cells with tumor information.
This research project funded by the European Commission aims for the development of an effective immunotherapy for breast cancer, based on dendritic cell vaccines.
Each of these strategies has its advantages and it is still unclear how to recruite the multiple components of the immune system most effectively to eliminate tumor cells - a question this project is committed to answer.
http://www.fz-juelich.de/ibt/cancer-immunotherapy

  
 Cancer Immunology Immunotherapy
is to eliminate breast cancer by leading innovation in research,
The mission of the California Breast Cancer Research Program
Associated Grant : Receptor Antibody-Enhanced Chemotherapy for Breast Cancer
http://www.cbcrp.org/research/PagePeriodical.asp?periodical_id=903

  
 Periodic Table: Actinium
Actinium Pharmaceuticals Announces Collaboration with Memorial Sloan Kettering Cancer Center for a Novel Targeted Cancer Immunotherapy.
Additional search results provided by HighBeam Research, LLC.
Isonics to Present Production Update on Rare Biomedical Isotopes at Society of Nuclear Medicine's 52nd Annual Meeting in Toronto; Company to Highlight its New Agreements to Supply Actinium-225 and Indium-111 Isotopes to Cancer Researchers.
http://www.infoplease.com/periodictable.php?id=89

 About us   |  Why use us?   |  Press   |  Contact us

 Copyright © 2006 Medicow.com Usage implies agreement with terms.